BackDeciphera Pharmaceuticals Overview
Deciphera Pharmaceuticals Inc

Deciphera Pharmaceuticals PEG Ratio

Latest PEG ratio for Deciphera Pharmaceuticals: 122.48 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

122.48

PEG Ratio

122.48

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

Deciphera Pharmaceuticals (DCPH) FAQ

As of the most recent data, DCPH shows a PEG ratio of 122.48. That is above the Healthcare sector average of 12.15. Scroll down for historical charts and peer comparison views.

The Healthcare sector average PEG ratio is about 12.15. Deciphera Pharmaceuticals is at 122.48, which is higher that average. That is roughly 907.9% above the sector mean. Use the comparison chart on this page to see how DCPH stacks up against individual peers as well.

Investors watch DCPH's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Deciphera Pharmaceuticals's latest reading is 122.48. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this peg ratio page, Stockcircle has Deciphera Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 122.48) with ownership activity and broader fundamentals.

The Healthcare average PEG ratio is about 12.15, while DCPH is at 122.48. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.